Kiniksa Pharmaceuticals International, plc Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Kiniksa Pharmaceuticals International, plc share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 319.83K shares, a 16.52% decline from fiscal 2022.
- Kiniksa Pharmaceuticals International, plc share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 383.11K shares, a 51.84% decline from fiscal 2021.
- Kiniksa Pharmaceuticals International, plc share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2021 was 795.40K shares, a 39.94% decline from fiscal 2020.
- Kiniksa Pharmaceuticals International, plc share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2020 was 1.32M shares, a 781.47% increase from fiscal 2019.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2023-12-31 | 319.83K shares 10-K · filed 2024-02-28 | |
| 2022-12-31 | 383.11K shares 10-K · filed 2024-02-28 | |
| 2021-12-31 | 795.40K shares 10-K · filed 2024-02-28 | |
| 2020-12-31 | 1.32M shares 10-K · filed 2023-03-02 | |
| 2019-12-31 | 150.25K shares 10-K · filed 2022-02-24 |